정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
37 | Not yet recruiting | Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19 | COVID-19 | Drug: prophylactic lactoferrin daily | Phase 3 | Cairo University | OTHER | 200 | All | 18 Years ~ 65 Years | |
36 | Not yet recruiting | Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19 | COVID-19 | Drug: Lactoferrin | Phase 3 | Cairo University | OTHER | 150 | All | 18 Years ~ 65 Years | |
35 | Not yet recruiting | Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication | COVID-19 | Combination Product: Combination therapy plus Standard therapy Radiation: Photodynamic therapy Drug: Standard therapy |
Phase 2 | Amr kamel khalil Ahmed, Faculty of Medicine , Kafrelshiekh University, Egypt. | OTHER_GOV | 2 | All | 18 Years ~ 70 Years | Ministry of health.First health cluster ,Riaydh, Riyadh, Saudi Arabia |
34 | Suspended | VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL) | COVID-19 | Drug: Hydroxychloroquine Drug: Azithromycin Drug: Placebo oral tablet |
Phase 3 | Salomeh Keyhani MD, San Francisco VA Health Care System | FED | 300 | All | 216 Months | San Francisco VA, San Francisco, California, United States |
33 | Active, not recruiting | Vaccination Against COVID-19 in Cancer | Cancer | Biological: mRNA-1273 SARS-CoV-2 vaccine from Moderna | Not Applicable | University Medical Center Groningen | OTHER | 791 | All | 18 Years | NKI-AvL, Amsterdam, Netherlands UMCG, Groningen, Netherlands Erasmus MC, Rotterdam, Netherlands |
32 | Recruiting | Vaccination Against Influenza to Prevent Cardiovascular Events After Acute Coronary Syndromes | Acute Coronary Syndrome | Biological: Double Dose Quadrivalent Influenza Vaccine Biological: Standard Dose Quadrivalent Influenza Vaccine |
Phase 3 | Hospital Israelita Albert Einstein, Ministry of Health, Brazil | OTHER | 1800 | All | 18 Years | Hospital e Clinica Sao Roque, Ipiau, Bahia, Brazil Hospital Ana Nery, Salvador, Bahia, Brazil Hospital Cardio Pulmonar, Salvador, Bahia, Brazil Universidade Federal do Ceara / Hospital Universitario Walter Cantidio, Fortaleza, Ceara, Brazil Instituto de Cardiologia do Distrito Federal, Brasilia, DF, Brazil Hospital Santa Lucia, Pocos De Caldas, MG, Brazil Hospital Universitario Ciencias Medicas, Belo Horizonte, Minas Gerais, Brazil Hospital Universitario da Universidade Estadual de Londrina, Londrina, Parana, Brazil Hospital Agamenon Magalhaes, Recife, Pernambuco, Brazil Pronto Socorro Cardiologico de Pernambuco, Recife, PE, Brazil Hospital Sao Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil Instituto Estadual de Cardiologia Aloysio de Castro, Rio De Janeiro, RJ, Brazil Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil IPEMI - Instituto de Pesquisas Medicas de Itajai, Itajai, Santa Catarina, Brazil Hospital Dona Helena, Joinville, Santa Catarina, Brazil Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil Centro de Pesquisa Clinica do Coracao, Aracaju, Sergipe, Brazil Faculdade de Medicina de Botucatu - UNESP, Botucatu, SP, Brazil Irmandade da Santa Casa de Misericordia de Marilia, Marilia, SP, Brazil Instituto do Coracao - HC FMUSP, Sao Paulo, SP, Brazil Santa Casa de Misericordia de Presidente Prudente, Presidente Prudente, Sao Paulo, Brazil Instituto Dante Pazzanese, Sao Paulo, Brazil |
31 | Recruiting | Vaccination for Recovered Inpatients With COVID-19 (VATICO) | Covid19 | Biological: Moderna mRNA-1273 COVID-19 vaccine Biological: Pfizer BNT162b2 COVID-19 vaccine |
Phase 4 | International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), University of Copenhagen, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury (PETAL), Cardiothoracic Surgical Trials Network (CTSN), Medical Research Council | NETWORK | 640 | All | 18 Years | Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Blvd, Los Angeles, California, United States Stanford University Hospitals & Clinics (Site 203-003), Stanford University, School of Medicine, 300 Pasteur Dr., Grant Bldg, Room S011, Stanford, California, United States Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 066-002), 1124 W. Carson St., CDCRC, Torrance, California, United States Public Health Institute at Denver Health (Site 017-004), 660 Bannock Street, Denver, Colorado, United States Washington DC VA Medical Center (Site 009-004), 50 Irving Street, NW., Washington, District of Columbia, United States Hillsborough County Health Department, University of South Florida (Site 032-001), 1105 E. Kennedy Blvd., Tampa, Florida, United States Minneapolis VA Medical Center (Site 105-001), 1 Veterans Drive, Minneapolis, Minnesota, United States Duke University Hospital (Site 301-006), 2301 Erwin Road, Durham, North Carolina, United States Wake Forest Baptist Health (Site 210-001), Medical Center Boulevard, Winston-Salem, North Carolina, United States Rhode Island Hospital (Site 080-036), 593 Eddy St., Providence, Rhode Island, United States The Miriam Hospital (Site 080-039), 164 Summit Ave., Providence, Rhode Island, United States CHRISTUS Spohn Shoreline Hospital (Site 080-001), 600 Elizabeth Street, Corpus Christi, Texas, United States UT Southwestern Medical Center (Site 084-001), 1936 Amelia Court, 2nd Floor, Dallas, Texas, United States Parkland Health and Hospital Systems (Site 084-002), James Aston Ambulatory Care Center - Clinical Research Unit, 5303 Harry Hines Blvd., Ste U-9.300, Dallas, Texas, United States Hospital Universitari Vall d'Hebron (Site 626-033), Passeig Vall Hebron, 119-129, Barcelona, Spain Hospital Clinic de Barcelona (Site 626-004), Carrer de Villaroel 170, Barcelona, Spain Hospital Universitari Germans Trias i Pujol (Site 626-003) Carretera de Canyet, s/n, Barcelona, Spain Hospital Universitari Arnau de Vilanova (Site 026-035), Institut de Recerca Biomedica de Lleida, Av. Rovira Roure, 80, Lleida, Spain Hospital General Universitario Gregorio Maranon (Site 626-001), Servicio de Inmunologia Clinica, Departamento de Medicina Interna, Dr. Esquerdo, 46, Madrid, Spain MRC/UVRI & LSHTM Uganda Research Unit (Site 634-601), Plot 51-59 Nakiwogo Road, P.O. Box 49, Entebbe, Uganda Gulu Regional Referral Hospital (Site 634-603), P.O. Box 160, Gulu, Uganda St. Francis Hospital, Nsambya (Site 634-607), Nsambya Road Nsambya Hill, P.O. Box 7146, Kampala, Uganda Makerere University Lung Institute (634-604), Mulago National Referral Hospital, Kampala, Uganda Lira Regional Referral Hospital (Site 634-605), Plot 9/19, 21-41 Ngetta Road Police Road, Lira, Uganda Masaka Regional Referral Hospital (Site 634-606), MRC/UVRI and LSHTM Uganda Research Unit, Plot 6 Circle Road, PO Box 556, Masaka, Uganda |